Ftse Mib
38.504,19
2,04%
DAX
23.081,03
3,37%
S&P 500
5.859,28
1,40%
NASDAQ
18.552,04
1,46%
Bitcoin
90.010,17
3,19%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Mirum Pharmaceuticals Inc (MIRM) Mirum Pharmaceuticals Inc (MIRM) Notizie

Mirum Pharmaceuticals Inc

MIRM
44,615
-0,605 (-1,34%)
Ultimo aggiornamento: 20:59:06
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
26/2/202522:17EDGAR2Form S-8 - Securities to be offered to employees in employee..
26/2/202522:09EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26/2/202522:06EDGAR2Form 8-K - Current report
26/2/202522:01BWMirum Pharmaceuticals Reports Fourth Quarter and Year-End..
24/2/202514:30BWMirum’s CTEXLI™ (chenodiol) Tablets Receives FDA Approval..
19/2/202522:04BWMirum Pharmaceuticals to Announce Fourth Quarter and..
11/2/202501:00BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
04/2/202523:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/1/202522:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202523:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/1/202514:32EDGAR2Form 8-K - Current report
13/1/202514:30BWMirum Pharmaceuticals Announces Preliminary Unaudited 2024..
11/1/202500:30BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
08/1/202522:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202522:04BWMirum Pharmaceuticals to Present at the 43rd Annual J.P...
11/12/202400:00BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
15/11/202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202414:00BWMirum Pharmaceuticals to Showcase Data from its LIVMARLI and..
12/11/202417:44EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202414:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202414:00BWMirum Pharmaceuticals Reports Third Quarter 2024 Financial..
09/11/202400:30BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
07/11/202422:30BWMirum Pharmaceuticals to Participate in Upcoming Investor..
04/11/202422:30BWMirum Pharmaceuticals to Announce Third Quarter 2024..
31/10/202413:30BWMirum Pharmaceuticals to Showcase LIVMARLI Data from its..
11/10/202401:30BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
10/10/202414:30BWVolixibat Granted Breakthrough Therapy Designation for..
11/9/202402:45BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
28/8/202422:01BWMirum Pharmaceuticals to Participate in Upcoming Investor..
10/8/202401:00BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
07/8/202422:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202422:06EDGAR2Form 8-K - Current report
07/8/202422:01BWMirum Pharmaceuticals Reports Second Quarter 2024 Financial..
31/7/202422:30BWMirum Pharmaceuticals to Announce Second Quarter 2024..
25/7/202414:30BWMirum’s LIVMARLI Now Approved for PFIC in Patients 12 Months..
11/7/202401:00BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
08/7/202422:46BWApprobation du LIVMARLI de Mirum Pharmaceuticals dans..
08/7/202422:20BWLIVMARLI von Mirum Pharmaceuticals wird in der Europäischen..
08/7/202414:30BWMirum Pharmaceuticals’ LIVMARLI Approved in the European..
28/6/202414:30BWMirum Submits New Drug Application to FDA for Chenodiol for..
17/6/202414:03EDGAR2Form 8-K - Current report
17/6/202414:00BWMirum’s Volixibat Achieves Positive Interim Analyses in..
16/6/202423:00BWMirum Pharmaceuticals to Host Investor Call to Share Interim..
11/6/202404:00BWMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq..
08/6/202400:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202406:04BWLangfristige Daten aus den LIVMARLI-Studien von Mirum bei..
06/6/202422:38EDGAR2Form 8-K - Current report
06/6/202415:30BWLong-Term Data from Mirum’s LIVMARLI Studies in ALGS and..
05/6/202422:05BWMirum Pharmaceuticals to Present at the Goldman Sachs 45th..
31/5/202423:02BWMirum Pharmaceuticals: positive CHMP-Stellungnahme für..
Apertura: 45,96 Min: 44,205 Max: 46,095
Chiusura: 45,22

La tua Cronologia

NASDAQ
MIRM
Mirum Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci